Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Business

    Jump to

    • Vishvaraj Environment, SAEL Industries, NoPaperForms, Symbiotec Pharmalab among six IPOs to get SEBI nod

      The SEBI has issued observations on the draft documents of Prasol Chemicals, NoPaperForms Solutions, and Symbiotec Pharmalab on March 25, while the observations on IPO papers of Shah Investor's Home, Vishvaraj Environment, and SAEL Industries were issued on March 27.

    • The Reading List: March 27, 2026

      Our research and opinion teams have curated a selection of articles and social media gems from the world of economy, business and finance for your weekend read.

    • Hetero kicks-off generic semaglutide rollout in overseas markets

      Initial exports are underway across parts of Africa, Asia and the Middle East, with additional launches planned as regulatory approvals come through.

    • Jupiter Hospitals wins 80-year lease for 400-bed hospital in Mumbai's BKC

      The company paid Rs 354 crore for the land parcel. On a land‑only basis, the deal implies an upfront cost of roughly Rs 0.9 crore per planned bed — before factoring in build and operating expenses

    • IPO-bound Turtlemint Fintech plans to invest in tech, cloud infra to drive growth

      Turtlemint Fintech Solutions has earmarked Rs 193.04 crore for strengthening its technology and product development teams and Rs 25.64 crore for cloud and server infrastructure, according to updated draft documents.

    • Mom's Belief parent raises Rs 2.3 crore from Myong Zin Park in pre-IPO round at Rs 622 crore valuation

      Rays of Belief IPO| The pre-IPO placement was approved by the Board on March 18, and the shareholders on March 19.

    • Iran war cripples Indian carriers, 75% of Gulf flights scrapped

      Not just connectivity, the disruption strikes at the heart of airline revenues, with West Asia accounting for nearly half of the country’s international passenger traffic

    • Dhurandhar’s blockbuster run points to box office shifting beyond first-week dependence

      First-week share of lifetime earnings falls sharply over a decade

    • As Strides Pharma stabilises balance sheet, focus shifts to growth beyond the US

      “We are not looking to enter completely new or unrelated segments..the strategy is to build on our existing capabilities — manufacturing, regulatory, and commercial,” Aditya Kumar said.

    • Bharat Pet files draft papers for Rs 760-crore IPO; issue largely an offer for sale

      Bharat Pet IPO | The company approached capital markets to raise Rs 120 crore by issuing fresh shares, while promoters will be selling shares worth Rs 640 crore.

    • Highness Microelectronics IPO garners strong demand from investors, sees 8.13 times subscription on day 2

      Highness Microelectronics IPO | The initial public offering is a mix of fresh issue of 16.53 lakh shares worth Rs 19.84 crore, and an offer-for-sale of 1.52 lakh shares amounting to Rs 1.82 crore by promoters.

    • Tipco Engineering India IPO closes with 1.56 times subscription; check allotment, listing dates

      Tipco Engineering IPO | The company tapped capital markets to raise Rs 60.55 crore via public issue of 68.03 lakh shares at the upper end of price band of Rs 84-89 per share.

    • Karuppu: Trisha Krishnan–Suriya starrer drives Rs 110 crore pre-release business ahead of big-ticket release

      Suriya and Trisha’s Karuppu secures over Rs 110 crore in pre-release business, recovering most of its budget. Strong distributor confidence and music buzz position it as a major commercial contender.

    • Sai Parenteral's IPO subscribed 41% on Day 2

      The IPO comprises a fresh issue of up to Rs 285 crore and an offer-for-sale of up to nearly 32 lakh equity shares

    • Auto makers activate 'Plan B' as gas crunch hits component suppliers 

      With Tier 2 and 3 suppliers bearing the brunt of the disruption, the supply crunch is threatening to derail production cycles across segments, even as strong vehicle demand keeps pressure on manufacturers to maintain output

    • Novo Nordisk betting on clinical depth not discounts to take on low-cost generics, says Vikrant Shrotriya

      The patent expiry of semaglutide injections sold by Novo Nordisk as Ozempic and Wegovy has pitted the Danish firm against at least 50 generic brands in India

    • OPINION | When Indian business family heads cannot say ‘no’

      In many Indian business families, the hardest word is not succession. It is the ability to say “no” — on roles, strategy, family & business decisions where blood, governance and stakeholder interests collide 

    • OPINION | The Liquidation Question: Is IBC resolving businesses or simply closing them faster?

      The pragmatic answer is that IBC is doing both. It is resolving businesses where there is genuine economic value left

    • Railway EPC services provider Laxyo files draft papers to raise Rs 150 crore via IPO

      Laxyo IPO | The offer comprises of entirely fresh issue with no offer-for-sale component.

    • Speciality Medicines IPO subscribed 2.19 times on final day; QIB portion booked 96x by just 2 investors

      Speciality Medicines IPO | The company approached the capital markets to raise Rs 29.14 crore through a public issue of 23.5 lakh shares.

    • Vivid Electromech IPO to open on March 25, listing likely on April 6

      Vivid Electromech IPO | The Maharashtra-based company is raising Rs 130.5 crore via initial public offering at the upper price band, valuing it at Rs 493 crore.

    • Sai Parenteral's IPO subscribed 4% on Day 1

      The company garnered more than Rs 122 crore from anchor investors on Monday

    • Business activity slows to 41-month low in March as Iran war bites

      Manufacturing activity slowed sharply, with the PMI dropping to a 54-month low of to 53.8, indicating that factory output and new orders have taken a hit

    • Medical device makers warn of crisis, seek quick GST refunds, control on freight charges

      AiMeD’s wants the government to come good on its promise to refund excess GST within seven days, a commitment the industry says has not been met

    • OPINION | Unlocking Shareholder Value: The case for re-evaluating India's share buyback regulations

      Regulatory framework for buybacks is set to become more complicated on April 1. Instead, if government trusts boards to take the best option on capital structure through free buybacks, equity market will stabilise

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347